admin

/admin

About admin

This author has not yet filled in any details.
So far admin has created 17 blog entries.

GHIF Leads €16 Million Series B Financing for Univercells

Investment proceeds will support commercialization of the company’s breakthrough biologics manufacturing technology Univercells SA (‘Univercells’) and Global Health Investment Fund (‘GHIF’) are pleased to announce the closing of a €16 million ($18.8 million) Series B equity financing. Investment proceeds will support the continued development of Univercells’ game-changing biomanufacturing technology, which has the potential to dramatically [...]

By |2018-07-16T15:49:44+00:00July 16th, 2018|Uncategorized|0 Comments

GHIF Leads €10 Million Series C Financing for Themis Bioscience

  Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline Proceeds will support the further development of the company's chikungunya vaccine candidate VIENNA - January 4, 2018 - Themis announced today the close of a Series C financing round totaling EUR 10 million. Global Health Investment Fund (GHIF), a New York-based impact investment firm focused [...]

By |2018-02-23T14:44:40+00:00January 4th, 2018|Uncategorized|0 Comments

GHIF Performance Highlighted by KfW Development Bank

  Independent Review of GHIF Suggests the Fund is Performing Against Original Impact Investment Objectives Innovative financing model shows promise for supporting global health research and development in a sustainable manner FRANKFURT - December 21, 2016 - In mid-2016, KfW Development Bank, an anchor investor in GHIF, commissioned an independent mid-term review of the fund's performance [...]

By |2018-02-23T14:44:40+00:00December 21st, 2016|Uncategorized|0 Comments

GHIF Presents at Priority Review Voucher Summit

Press Release ### Global Health Investment Fund Managing Partner Curt LaBelle Speaks at Priority Review Voucher Summit Panel presentation covers PRV program’s impact on neglected disease research   NEW YORK - November 3, 2016 - Curt LaBelle, MD, Managing Partner of the Global Health Investment Fund, led a panel discussion yesterday on the impact of [...]

By |2018-02-23T14:44:40+00:00November 3rd, 2016|Uncategorized|0 Comments

GHIF Invests $8 Million in Access Bio, Inc.

Press Release ### Global Health Investment Fund Purchases $8 Million of Convertible Notes Issued by Access Bio, Inc. Proceeds will finance the purchase and installation of new manufacturing equipment for Access Bio’s rapid diagnostic test products   NEW YORK--The Global Health Investment Fund (“GHIF”) is pleased to announce that it has invested $8 million in [...]

By |2018-02-23T14:44:40+00:00March 30th, 2016|Uncategorized|0 Comments

GHIF Makes $6 Million Loan to Atomo Diagnostics

Press Release ### Atomo Secures $6 Million from the Global Health Investment Fund The investment will support scale up of Atomo’s global health activities, focusing on continued rollout of its award winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance January 13, 2016 (SYDNEY and NEW YORK): The Global Health [...]

By |2018-02-23T14:44:40+00:00January 14th, 2016|Uncategorized|0 Comments

GHIF-Backed EuBiologics Earns WHO Endorsement for Euvichol

From the World Health Organization:   Cholera vaccine supply set to double, easing global shortage 8 January 2016 Globally, OCV production is low, with demands currently exceeding supply. Sudan and Haiti last year made requests to WHO for supplies of vaccines to conduct pre-emptive vaccination campaigns that could not be filled because of the global [...]

By |2018-02-23T14:44:40+00:00January 10th, 2016|Uncategorized|0 Comments

Press Release: GHIF Finances Registration of Moxidectin for Onchocerciasis

$10 Million Investment into the Registration of Moxidectin, an Important New Global Health Medicine for River Blindness If approved, moxidectin is expected to significantly accelerate the eradication of this terrible neglected disease March 8, 2015 (LONDON – UK): The Global Health Investment Fund (GHIF) and Medicines Development for Global Health (Medicines Development) announced today a [...]

By |2018-02-23T14:44:40+00:00March 8th, 2015|Uncategorized|0 Comments

Press Release: GHIF Leads $7.5 Million Investment in Korean Vaccine Manufacturer

Global Health Investment Fund Leads 7.5 Million USD Investment into EuBiologics to Catalyze Availability of Low-Cost Oral Cholera Vaccine for the World’s Poor  Korean biopharmaceutical company commits to manufacture a new and improved presentation of the vaccine at a target price of $1.00 per dose for public sector buyers  August 27, 2014 (SEOUL): Global Health [...]

By |2018-02-23T14:44:40+00:00August 27th, 2014|Uncategorized|0 Comments

Press Release: GHIF Purchases $8 Million Convertible Bond to Finance New TB Diagnostic

  Global Health Investment Fund Announcement of Collaborative Funding Agreement with Epistem PLC Investment will support the roll-out of Epistem's Genedrive® molecular diagnostic platform as the company's tuberculosis assay enters pivotal field trials in key developing world locations July 22, 2014 (LONDON): The Global Health Investment Fund I, LLC (GHIF), is pleased to announce today that it [...]

By |2018-02-23T14:44:40+00:00July 22nd, 2014|Uncategorized|0 Comments